(Q33704434)

28 July 2017

1 reference

title

Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders (English)

1 reference

28 July 2017

A A Farooqui

1

1 reference

28 July 2017

M L Litsky

series ordinal

2

1 reference

28 July 2017

T Farooqui

series ordinal

3

1 reference

28 July 2017

L A Horrocks

series ordinal

4

1 reference

28 July 2017

1 June 1999

1 reference

28 July 2017

Brain Research Bulletin

1 reference

28 July 2017

49

1 reference

28 July 2017

139-153

1 reference

28 July 2017

3

1 reference

Inhibition of macrophage Ca(2+)-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Mammalian calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Effects of CDP-choline on phospholipase A2 and cholinephosphotransferase activities following a cryogenic brain injury in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Function of calcium-independent phospholipase A2 in arachidonic acid metabolism in P388D1 macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Function and inhibition of intracellular calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Protein oxidation in aging, disease, and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Effect of ganglioside GM1 on arachidonic acid release in bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Oxidative stress mediates synthesis of cytosolic phospholipase A2 after UVB injury

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Lipid peroxidation contributes to age-related membrane rigidity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Enhanced processing of APP induced by IL-1 beta can be reduced by indomethacin and nordihydroguaiaretic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Biochemistry and pathology of radical-mediated protein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

The growing phospholipase A2 superfamily of signal transduction enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Vitamin E inhibits platelet phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Oxidative stress and antioxidant therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Activation of ethanolamine phospholipase A2 in Brain during ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Excitotoxicity and neurological disorders: involvement of membrane phospholipids.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Phospholipases, lysophospholipases, and lipases and their involvement in various diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Purification of lipases, phospholipases and kinases by heparin-Sepharose chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Plasmalogens, phospholipases A2 and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Involvement of phospholipase A2 in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Phospholipase A2 and its role in brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Blockade of long-term depression in neonatal hippocampal slices by a phospholipase A2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Chemical modification and inactivation of phospholipases A2 by a manoalide analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Excitotoxin induction of ornithine decarboxylase in cerebral cortex is reduced by phospholipase A2 inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Annexins and membrane dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Killing of endothelial cells and release of arachidonic acid. Synergistic effects among hydrogen peroxide, membrane-damaging agents, cationic substances, and proteinases and their modulation by inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Phospholipase A2 enzymes: regulation and inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

The purification and characterization of a phospholipase A2 activity from the 106,000 X g pellet (microsomal fraction) of bovine brain acting on phosphatidylinositol

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Interleukin 1 alpha causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

The Alzheimer family of diseases: many etiologies, one pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

GM1 ganglioside treatment of spontaneously hypertensive stroke prone rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Identification and purification of calcium-independent phospholipase A2 from bovine brain cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Quinacrine acts like an acetylcholine receptor antagonist rather than like a phospholipase A2 inhibitor in a passive avoidance task in the chick.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Inhibitors of phospholipase A2 produce amnesia for a passive avoidance task in the chick.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Secretory phospholipase A2 inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Functional identification of the active-site nucleophile of the human 85-kDa cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Effects of organometals on cellular signaling. I. Influence of metabolic inhibitors on metal-induced arachidonic acid liberation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Arachidonic acid modulates hippocampal calcium current via protein kinase C and oxygen radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Peroxynitrite-mediated oxidation of dihydrorhodamine 123

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Cytosolic phospholipase A2 (cPLA2) and lipid mediator release in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

3-(3,5-Dimethyl-4-octadecanoylpyrrol-2-yl)propionic acids as inhibitors of 85 kDa cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

3-(Octadecanoylaminomethyl)indole-2-carboxylic acid derivatives and 1-methyl-3-octadecanoylindole-2-carboxylic acid as inhibitors of cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Synthesis, biological evaluation, and structure-activity relationships of 3-acylindole-2-carboxylic acids as inhibitors of the cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Properties and regulation of cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

The mode of action of nerve growth factor in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Selective inhibition of cytosolic phospholipase A2 in activated human monocytes. Regulation of superoxide anion production and low density lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Selective inhibition of group II phospholipase A2 by quercetin

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Inhibition of Monocyte Chemotaxis to C-C Chemokines by Antisense Oligonucleotide for Cytosolic Phospholipase A

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

A Specific Inhibitor of Cytosolic Phospholipase A2Activity, AACOCF3, Inhibits Glucose-Induced Insulin Secretion from Isolated Rat Islets

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Nordihydroguaiaretic acid suppression of rat mammary carcinogenesis induced by N-methyl-N-nitrosourea.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Making sense out of antisense for the study of drug receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Synthesis and biological evaluation of substituted benzenesulfonamides as novel potent membrane-bound phospholipase A2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Inhibition of tumoral cell respiration and growth by nordihydroguaiaretic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Cerebroprotective action of the phospholipase inhibitor quinacrine in the ischemia/reperfused gerbil hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Purification of a novel calcium-independent phospholipase A2 from rabbit kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Inhibition of bioenergetics alters intracellular calcium, membrane composition, and fluidity in a neuronal cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Characterization of phospholipase A2 (PLA2) activity in gerbil brain: enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Characterization of a novel phospholipase A2 activity in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Nordihydroguaiaretic acid attenuates NMDA neurotoxicity--action beyond the receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Oxidative stress and mitochondrial dysfunction in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Brain phospholipase A2 is activated after experimental closed head injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Rapid regulation of neurite outgrowth and retraction by phospholipase A2-derived arachidonic acid and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Effects of arachidonyltrifluoromethyl ketone on cytosolic [Ca2+] in HIT insulinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

The biphasic effect of phospholipase A2 inhibitors on axon elongation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Early changes of surface morphology in monolayer cultures of neural retina cells. The effect of p-bromophenacyl bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Gangliosides--a new therapeutic agent against stroke and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Transfection of C3H10T1/2 cells with the Harvey-ras oncogene reduces cytosolic phospholipase A2 function

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Purification of a phosphatidic-acid-hydrolysing phospholipase A2 from rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Cell swelling activates phospholipase A2 in Ehrlich ascites tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

A reassessment of the low molecular weight phospholipase A2 gene family in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Vitamin E: beyond antioxidant function

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Vitamin E potentiates arachidonate release and phospholipase A2 activity in rat heart myoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

NMR structural studies of the tight complex between a trifluoromethyl ketone inhibitor and the 85-kDa human phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Inhibitors of arachidonic acid metabolism reduce DNA and nuclear fragmentation induced by TNF plus cycloheximide in U937 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Expression, purification, and kinetic characterization of a recombinant 80-kDa intracellular calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Long-term potentiation requires activation of calcium-independent phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

P11, a unique member of the S100 family of calcium-binding proteins, interacts with and inhibits the activity of the 85-kDa cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Elevation of serum group II phospholipase A2 levels in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. II. Dose-response effect and the therapeutic window.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Effects of glycosaminoglycans and glycosphingolipids on cytosolic phospholipases A2 from bovine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Effects of sialic acid and sialoglycoconjugates on cytosolic phospholipases A2 from bovine brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Isolation and properties of a novel phospholipase A from rat brain that hydrolyses fatty acids at sn-1 and sn-2 positions.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Translocation of phospholipase A2 from cytosol to membranes in rat brain induced by calcium ions.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

Structural determinants of haloenol lactone-mediated suicide inhibition of canine myocardial calcium-independent phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900027-1

7 January 2021

10.1016/S0361-9230(99)00027-1

Identifiers

DOI

1 reference

28 July 2017

1 reference